Abdel Hamid

722 total citations
6 papers, 92 citations indexed

About

Abdel Hamid is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Abdel Hamid has authored 6 papers receiving a total of 92 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Abdel Hamid's work include Cancer Genomics and Diagnostics (2 papers), Renal cell carcinoma treatment (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Abdel Hamid is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Renal cell carcinoma treatment (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Abdel Hamid collaborates with scholars based in Egypt, United Kingdom and Malaysia. Abdel Hamid's co-authors include Leslie G. Walker, Donald Sharp, Andrew A. Walker, Mary B. Walker, Sunil Upadhyay, A. Shafik, Javier Puente, Ryan J. Hartmaier, Alexander Laird and Iosif Mendichovszky and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and European Surgical Research.

In The Last Decade

Abdel Hamid

6 papers receiving 88 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdel Hamid Egypt	3	47	36	18	16	15	6	92
Kimberly Richardson United States	6	58 1.2×	35 1.0×	18 1.0×	5 0.3×	11 0.7×	10	196
Elaine Chung United States	5	23 0.5×	31 0.9×	15 0.8×	48 3.0×	8 0.5×	8	177
Rama Balaraman United States	5	56 1.2×	6 0.2×	16 0.9×	5 0.3×	15 1.0×	12	127
Sam Chong United Kingdom	4	24 0.5×	11 0.3×	6 0.3×	20 1.3×	35 2.3×	4	100
Yuemei Li China	7	7 0.1×	29 0.8×	7 0.4×	7 0.4×	19 1.3×	22	142
Peter van Hengel Netherlands	6	31 0.7×	29 0.8×	165 9.2×	18 1.1×	3 0.2×	11	230
Rhona M. Fear United Kingdom	3	113 2.4×	4 0.1×	45 2.5×	3 0.2×	11 0.7×	4	175
Lidia Delrieu France	10	160 3.4×	5 0.1×	48 2.7×	15 0.9×	42 2.8×	31	260
Carol A DeNysschen United States	9	74 1.6×	5 0.1×	17 0.9×	9 0.6×	33 2.2×	11	197
Anita M.A.P. Govers Netherlands	5	4 0.1×	18 0.5×	7 0.4×	8 0.5×	59 3.9×	7	151

Countries citing papers authored by Abdel Hamid

Since Specialization

Citations

This map shows the geographic impact of Abdel Hamid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdel Hamid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdel Hamid more than expected).

Fields of papers citing papers by Abdel Hamid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdel Hamid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdel Hamid. The network helps show where Abdel Hamid may publish in the future.

Co-authorship network of co-authors of Abdel Hamid

This figure shows the co-authorship network connecting the top 25 collaborators of Abdel Hamid. A scholar is included among the top collaborators of Abdel Hamid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdel Hamid. Abdel Hamid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Powles, Thomas, María José Méndez-Vidal, Alejo Rodríguez‐Vida, et al.. (2022). CALYPSO: A three-arm randomized phase II study of durvalumab alone or with savolitinib or tremelimumab in previously treated advanced clear cell renal cancer.. Journal of Clinical Oncology. 40(17_suppl). LBA4503–LBA4503. 2 indexed citations

2.

Stewart, Grant D., Sarah J. Welsh, Stephan Ursprung, et al.. (2021). NAXIVA: A phase II neoadjuvant study of axitinib for reducing extent of venous tumor thrombus in clear cell renal cell cancer (RCC) with venous invasion.. Journal of Clinical Oncology. 39(6_suppl). 275–275. 6 indexed citations

3.

Hamid, Abdel, et al.. (2020). Expression of Tolerogenic HLA-G Confer Worse Outcome in Patients with Chronic Lymphocytic Leukemia. The Egyptian Journal of Hospital Medicine. 80(1). 587–593. 1 indexed citations

4.

Hamid, Abdel, et al.. (2020). Prognostic Value of Soluble HLA-G and CD38 Expression in Patients with Chronic Lymphocytic Leukemia in Egypt. The Egyptian Journal of Hospital Medicine. 80(1). 581–586. 1 indexed citations

5.

Sharp, Donald, Mary B. Walker, Sunil Upadhyay, et al.. (2009). A randomised, controlled trial of the psychological effects of reflexology in early breast cancer. European Journal of Cancer. 46(2). 312–322. 72 indexed citations

6.

Shafik, A., et al.. (1992). Involuntary Action of the External Anal Sphincter. European Surgical Research. 24(3). 188–196. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact